YAP is a candidate oncogene for esophageal squamous cell carcinoma

Tomoki Muramatsu, Issei Imoto, Takeshi Matsui, Ken Ichi Kozaki, Shigeo Haruki, Marius Sudol, Yutaka Shimada, Hitoshi Tsuda, Tatsuyuki Kawano, Johji Inazawa

Research output: Contribution to journalArticle

139 Citations (Scopus)

Abstract

Yes-associated protein (YAP), the nuclear effector of the Hippo pathway, is a key regulator of organ size and a candidate human oncogene located at chromosome 11q22. Since we previously reported amplification of 11q22 region in esophageal squamous cell carcinoma (ESCC), in this study we focused on the clinical significance and biological functions of YAP in this tumor. Frequent overexpression of YAP protein was observed in ESCC cells including those with a robust amplicon at position 11q22. Overexpression of the YAP protein was frequently detected in primary tumors of ESCC as well. Patients with YAP-overexpressing tumors had a worse overall rate of survival than those with non-expressing tumors, and YAP positivity was independently associated with a worse outcome in the multivariate analysis. Further analyses in cells in which YAP was either overexpressed or depleted confirmed that cell proliferation was promoted in a YAP isoform-independent but YAP expression level-dependent manner. YAP depletion inhibited cell proliferation mainly in the G0-G1 phase and induced an increase in CDKN1A/p21 transcription but a decrease in BIRC5/survivin transcription. Our results indicate that YAP is a putative oncogene in ESCC and it represents a potential diagnostic and therapeutic target.

Original languageEnglish
Pages (from-to)389-398
Number of pages10
JournalCarcinogenesis
Volume32
Issue number3
DOIs
Publication statusPublished - 2011
Externally publishedYes

Fingerprint

Oncogenes
Proteins
Neoplasms
Esophageal Squamous Cell Carcinoma
Cell Proliferation
Cell Cycle Resting Phase
Organ Size
G1 Phase
Nuclear Proteins
Protein Isoforms
Multivariate Analysis
Survival Rate
Chromosomes

ASJC Scopus subject areas

  • Cancer Research

Cite this

Muramatsu, T., Imoto, I., Matsui, T., Kozaki, K. I., Haruki, S., Sudol, M., ... Inazawa, J. (2011). YAP is a candidate oncogene for esophageal squamous cell carcinoma. Carcinogenesis, 32(3), 389-398. https://doi.org/10.1093/carcin/bgq254

YAP is a candidate oncogene for esophageal squamous cell carcinoma. / Muramatsu, Tomoki; Imoto, Issei; Matsui, Takeshi; Kozaki, Ken Ichi; Haruki, Shigeo; Sudol, Marius; Shimada, Yutaka; Tsuda, Hitoshi; Kawano, Tatsuyuki; Inazawa, Johji.

In: Carcinogenesis, Vol. 32, No. 3, 2011, p. 389-398.

Research output: Contribution to journalArticle

Muramatsu, T, Imoto, I, Matsui, T, Kozaki, KI, Haruki, S, Sudol, M, Shimada, Y, Tsuda, H, Kawano, T & Inazawa, J 2011, 'YAP is a candidate oncogene for esophageal squamous cell carcinoma', Carcinogenesis, vol. 32, no. 3, pp. 389-398. https://doi.org/10.1093/carcin/bgq254
Muramatsu T, Imoto I, Matsui T, Kozaki KI, Haruki S, Sudol M et al. YAP is a candidate oncogene for esophageal squamous cell carcinoma. Carcinogenesis. 2011;32(3):389-398. https://doi.org/10.1093/carcin/bgq254
Muramatsu, Tomoki ; Imoto, Issei ; Matsui, Takeshi ; Kozaki, Ken Ichi ; Haruki, Shigeo ; Sudol, Marius ; Shimada, Yutaka ; Tsuda, Hitoshi ; Kawano, Tatsuyuki ; Inazawa, Johji. / YAP is a candidate oncogene for esophageal squamous cell carcinoma. In: Carcinogenesis. 2011 ; Vol. 32, No. 3. pp. 389-398.
@article{978d069a65b740399da5c87956f5c16e,
title = "YAP is a candidate oncogene for esophageal squamous cell carcinoma",
abstract = "Yes-associated protein (YAP), the nuclear effector of the Hippo pathway, is a key regulator of organ size and a candidate human oncogene located at chromosome 11q22. Since we previously reported amplification of 11q22 region in esophageal squamous cell carcinoma (ESCC), in this study we focused on the clinical significance and biological functions of YAP in this tumor. Frequent overexpression of YAP protein was observed in ESCC cells including those with a robust amplicon at position 11q22. Overexpression of the YAP protein was frequently detected in primary tumors of ESCC as well. Patients with YAP-overexpressing tumors had a worse overall rate of survival than those with non-expressing tumors, and YAP positivity was independently associated with a worse outcome in the multivariate analysis. Further analyses in cells in which YAP was either overexpressed or depleted confirmed that cell proliferation was promoted in a YAP isoform-independent but YAP expression level-dependent manner. YAP depletion inhibited cell proliferation mainly in the G0-G1 phase and induced an increase in CDKN1A/p21 transcription but a decrease in BIRC5/survivin transcription. Our results indicate that YAP is a putative oncogene in ESCC and it represents a potential diagnostic and therapeutic target.",
author = "Tomoki Muramatsu and Issei Imoto and Takeshi Matsui and Kozaki, {Ken Ichi} and Shigeo Haruki and Marius Sudol and Yutaka Shimada and Hitoshi Tsuda and Tatsuyuki Kawano and Johji Inazawa",
year = "2011",
doi = "10.1093/carcin/bgq254",
language = "English",
volume = "32",
pages = "389--398",
journal = "Carcinogenesis",
issn = "0143-3334",
publisher = "Oxford University Press",
number = "3",

}

TY - JOUR

T1 - YAP is a candidate oncogene for esophageal squamous cell carcinoma

AU - Muramatsu, Tomoki

AU - Imoto, Issei

AU - Matsui, Takeshi

AU - Kozaki, Ken Ichi

AU - Haruki, Shigeo

AU - Sudol, Marius

AU - Shimada, Yutaka

AU - Tsuda, Hitoshi

AU - Kawano, Tatsuyuki

AU - Inazawa, Johji

PY - 2011

Y1 - 2011

N2 - Yes-associated protein (YAP), the nuclear effector of the Hippo pathway, is a key regulator of organ size and a candidate human oncogene located at chromosome 11q22. Since we previously reported amplification of 11q22 region in esophageal squamous cell carcinoma (ESCC), in this study we focused on the clinical significance and biological functions of YAP in this tumor. Frequent overexpression of YAP protein was observed in ESCC cells including those with a robust amplicon at position 11q22. Overexpression of the YAP protein was frequently detected in primary tumors of ESCC as well. Patients with YAP-overexpressing tumors had a worse overall rate of survival than those with non-expressing tumors, and YAP positivity was independently associated with a worse outcome in the multivariate analysis. Further analyses in cells in which YAP was either overexpressed or depleted confirmed that cell proliferation was promoted in a YAP isoform-independent but YAP expression level-dependent manner. YAP depletion inhibited cell proliferation mainly in the G0-G1 phase and induced an increase in CDKN1A/p21 transcription but a decrease in BIRC5/survivin transcription. Our results indicate that YAP is a putative oncogene in ESCC and it represents a potential diagnostic and therapeutic target.

AB - Yes-associated protein (YAP), the nuclear effector of the Hippo pathway, is a key regulator of organ size and a candidate human oncogene located at chromosome 11q22. Since we previously reported amplification of 11q22 region in esophageal squamous cell carcinoma (ESCC), in this study we focused on the clinical significance and biological functions of YAP in this tumor. Frequent overexpression of YAP protein was observed in ESCC cells including those with a robust amplicon at position 11q22. Overexpression of the YAP protein was frequently detected in primary tumors of ESCC as well. Patients with YAP-overexpressing tumors had a worse overall rate of survival than those with non-expressing tumors, and YAP positivity was independently associated with a worse outcome in the multivariate analysis. Further analyses in cells in which YAP was either overexpressed or depleted confirmed that cell proliferation was promoted in a YAP isoform-independent but YAP expression level-dependent manner. YAP depletion inhibited cell proliferation mainly in the G0-G1 phase and induced an increase in CDKN1A/p21 transcription but a decrease in BIRC5/survivin transcription. Our results indicate that YAP is a putative oncogene in ESCC and it represents a potential diagnostic and therapeutic target.

UR - http://www.scopus.com/inward/record.url?scp=79952304497&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952304497&partnerID=8YFLogxK

U2 - 10.1093/carcin/bgq254

DO - 10.1093/carcin/bgq254

M3 - Article

C2 - 21112960

AN - SCOPUS:79952304497

VL - 32

SP - 389

EP - 398

JO - Carcinogenesis

JF - Carcinogenesis

SN - 0143-3334

IS - 3

ER -